Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

XHS vs XSW: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

XSW Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

XSW Overall Winner 6-Pillar Tally: XHS 0 – 0 XSW (6 Tie) Matrix Metrics: XHS 1 – 2 XSW

As of Nov 16, 2026, SPDR S&P Software & Services ETF (XSW) is the stronger overall head-to-head candidate over SPDR S&P Health Care Services ETF (XHS) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XHS carries a Unified Composite Score of 45.3/100 (HOLD) at $146.16 (N/M Forward P/E, N/A operating margin), whereas XSW carries 65.2/100 (BUY) at $204.07 (N/M Forward P/E, N/A operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XHS vs XSW
XHS NYSE Arca
SPDR S&P Health Care Services ETF
Institutional Equity
$146.16
+0.5% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.46β · 26% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 35.0 Fund 36.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 58
RSI-14: 57.7 · SMA20: $144.18 · SMA50: $139.12
XSW NYSE Arca Head-to-Head Winner
SPDR S&P Software & Services ETF
Institutional Equity
$204.07
-0.92% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.95β · 23% Vol
Unified Composite Score
65.2 / 100 BUY
Tech 72.0 Fund 60.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.2 · SMA20: $209.32 · SMA50: $203.25

6-Pillar Scorecard Institutional Category Breakdown (XHS 0 – 0 XSW)

Columns: Metric · XHS · XSW
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 111.4% (100th %ile) 23.1% (21st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XHS (1) vs XSW (2)
Institutional Metric XHS XSW Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
88% ($98–$152) 84% ($135–$217) Stronger Trend XHS
Beta / 30D Volatility
Risk Regime
0.46β · 26% Vol 0.95β · 23% Vol Lower Realized Risk XSW
Unified Institutional Score
Composite Signal
45.3 / 100 (HOLD) 65.2 / 100 (BUY) Higher Composite XSW
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon XHS +3.23 pp
XHS: +6.21% · XSW: +2.98%
3M Horizon XHS +5.44 pp
XHS: +9.01% · XSW: +3.57%
6M Horizon XHS +1.25 pp
XHS: +29.13% · XSW: +27.88%
1Y Horizon XHS +33.49 pp
XHS: +43.59% · XSW: +10.1%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XHS vs XSW. Trailing 12-month operating profitability (XHS N/A vs XSW N/A) and valuation multiples (XHS N/M vs XSW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

XHS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
XSW ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 111.4%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XSW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.1%
IV Percentile 21st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XSW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XHS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
XSW Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ XHS vs XSW Key Questions & Quantitative Answers

As of Nov 16, 2026, SPDR S&P Software & Services ETF (XSW) is the stronger overall head-to-head candidate over SPDR S&P Health Care Services ETF (XHS) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XHS carries a Unified Composite Score of 45.3/100 (HOLD) at $146.16 (N/M Forward P/E, N/A operating margin), whereas XSW carries 65.2/100 (BUY) at $204.07 (N/M Forward P/E, N/A operating margin). Technically, XHS sits in a Markup phase (RSI 57.7, UNCLASSIFIED options structure) and XSW sits in a Neutral phase (RSI 47.2, UNCLASSIFIED options structure).

XHS and XSW split Growth & Scale metrics: XHS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XSW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, XHS generates N/A in USD-normalized revenue versus N/A for XSW. In operating R&D and SG&A reinvestment, XHS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XSW.

XHS and XSW trade at balanced relative valuation multiples. XHS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XSW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XHS (N/A ROE) versus XSW (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, XHS carries 111.4% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.46β · 26% Vol realized risk). By comparison, XSW carries 23.1% implied volatility (21st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.95β · 23% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.